AdvtBy ,ETHealthWorldJoin the community of 2M+ industry professionals Subscribe to our newsletter to get latest insights & analysis.
Download ETHealthworld App Get Realtime updatesSave your favourite articles Scan to download AppNew Delhi: The Rajiv Gandhi Cancer Institute and Research Centre ( RGCIRC ) hosted a two day conference , “ Breast Cancer Update Conference 2024” for discussing newly discovered cancer treatment strategies and bringing them to clinical practice The two-day event highlighted findings from the American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), and San Antonio Breast Cancer Symposium (SABCS).The conference had sessions on emerging therapies, precision medicine , and patient-centered care, along with panel discussions and several workshops covering topics such as early-stage breast cancer, metastatic breast cancer, triple-negative breast cancer, and advanced treatment options such as immunotherapy and precision medicine.Renowned oncologists presented significant findings from recent studies and latest trials on targeted therapies, immunotherapy like Pembrolizumab , cyclin inhibitor tablets and many new drugs and surgical procedures along with radiation techniques and investigations which have made revolutionary changes in the outcome of breast cancer management.
These presentations provided valuable insights into innovative treatments and patient care strategies.Dr D C Doval, Chair Medical Oncology and Chief of Breast and Thoracic Services , RGCIRC informed that the conference provided an invaluable opportunity for professionals to learn from each other and stay abreast of the latest research and clinical practices worldwide.Interactive panel discussions helped in robust exchanges of ideas and experiences among top oncologists, researchers, and clinicians.
Panels covered critical subjects such as high-risk breast cancer, metastatic breast cancer, and the evolving role of immunotherapy in treatment protocols.
Advt
By ,
ETHealthWorld
Join the community of 2M+ industry professionals Subscribe to our newsletter to get latest insights & analysis. Download ETHealthworld App Get Realtime updates
Save your favourite articles Scan to download App
New Delhi: The Rajiv Gandhi Cancer Institute and Research Centre ( RGCIRC ) hosted a two day conference , “ Breast Cancer Update Conference 2024” for discussing newly discovered cancer treatment strategies and bringing them to clinical practice The two-day event highlighted findings from the American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), and San Antonio Breast Cancer Symposium (SABCS).The conference had sessions on emerging therapies, precision medicine , and patient-centered care, along with panel discussions and several workshops covering topics such as early-stage breast cancer, metastatic breast cancer, triple-negative breast cancer, and advanced treatment options such as immunotherapy and precision medicine.Renowned oncologists presented significant findings from recent studies and latest trials on targeted therapies, immunotherapy like Pembrolizumab , cyclin inhibitor tablets and many new drugs and surgical procedures along with radiation techniques and investigations which have made revolutionary changes in the outcome of breast cancer management. These presentations provided valuable insights into innovative treatments and patient care strategies.Dr D C Doval, Chair Medical Oncology and Chief of Breast and Thoracic Services , RGCIRC informed that the conference provided an invaluable opportunity for professionals to learn from each other and stay abreast of the latest research and clinical practices worldwide.Interactive panel discussions helped in robust exchanges of ideas and experiences among top oncologists, researchers, and clinicians. Panels covered critical subjects such as high-risk breast cancer, metastatic breast cancer, and the evolving role of immunotherapy in treatment protocols.
